Inspira Technologies was approached by a medical technology company in the industry to evaluate the operation of its proprietary key product in combination with the Inspira ART100 system. The evaluation was conducted by Inspira researchers. The test results exceeded 100% of the standard value for gas transfer at maximum flow. This series of evaluations confirmed that the integrated system met the specified requirements, performing to expectations without any technical malfunctions or abnormal effects on the blood.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on IINN:
- Inspira Technologies Unveils Lifesaving Cardiac Device
- Inspira Technologies Gains Israeli Approval for ART100 System
- Inspira Technologies’ ART 100System granted Israeli regulatory approval
- Inspira Technologies Targets Mechanical Ventilation Market
- Inspira Technologies announces business plan targets